Search Results - "Markov, Pavel O."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Cyclodextrin Polymers as a Promising Drug Carriers for Stabilization of Meropenem Solutions by Yakupova, Linara R, Skuredina, Anna A, Markov, Pavel O, Le-Deygen, Irina M, Kudryashova, Elena V

    Published in Applied sciences (01-03-2023)
    “…Here we report the development of new drug carriers for meropenem based on the hydroxypropyl-β-cyclodextrin (HPCD) polymers with variable linkers, namely,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements by Iusupov, Ildar R., Curreli, Francesca, Spiridonov, Evgeniy A., Markov, Pavel O., Ahmed, Shahad, Belov, Dmitry S., Manasova, Ekaterina V., Altieri, Andrea, Kurkin, Alexander V., Debnath, Asim K.

    Published in European journal of medicinal chemistry (15-11-2021)
    “…We present the development of alternative scaffolds and validation of their synthetic pathways as a tool for the exploration of new HIV gp120 inhibitors based…”
    Get full text
    Journal Article
  4. 4

    Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV‐1 Entry Inhibitor NBD‐14270 by Kurkin, Alexander V., Curreli, Francesca, Iusupov, Ildar R., Spiridonov, Evgeniy A., Ahmed, Shahad, Markov, Pavel O., Manasova, Ekaterina V., Altieri, Andrea, Debnath, Asim K.

    Published in ChemMedChem (18-11-2022)
    “…The envelope glycoprotein gp120 of human immunodeficiency virus type 1 (HIV‐1) plays a critical role in virus entry to the cells by binding to the host…”
    Get full text
    Journal Article
  5. 5

    Front Cover: Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV‐1 Entry Inhibitor NBD‐14270 (ChemMedChem 22/2022) by Kurkin, Alexander V., Curreli, Francesca, Iusupov, Ildar R., Spiridonov, Evgeniy A., Ahmed, Shahad, Markov, Pavel O., Manasova, Ekaterina V., Altieri, Andrea, Debnath, Asim K.

    Published in ChemMedChem (18-11-2022)
    “…The Front Cover shows the interactions of the HIV‐1 envelope glycoprotein gp120 with two sets of NBD compounds (HIV‐1 entry inhibitors) representing three…”
    Get full text
    Journal Article